227 related articles for article (PubMed ID: 32516368)
1. In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
Buil JB; Brüggemann RJM; Bedin Denardi L; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2020 Sep; 75(9):2582-2586. PubMed ID: 32516368
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
3. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
[TBL] [Abstract][Full Text] [Related]
4. In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.
Seyedmousavi S; Meletiadis J; Melchers WJ; Rijs AJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2013 Feb; 57(2):796-803. PubMed ID: 23183435
[TBL] [Abstract][Full Text] [Related]
5. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
[TBL] [Abstract][Full Text] [Related]
6. Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
Siopi M; Rivero-Menendez O; Gkotsis G; Panara A; Thomaidis NS; Alastruey-Izquierdo A; Pournaras S; Meletiadis J
J Antimicrob Chemother; 2020 Nov; 75(11):3181-3188. PubMed ID: 32814940
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus.
Snelders E; Camps SM; Karawajczyk A; Rijs AJ; Zoll J; Verweij PE; Melchers WJ
Fungal Genet Biol; 2015 Sep; 82():129-35. PubMed ID: 26092193
[TBL] [Abstract][Full Text] [Related]
8. First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.
Astvad KM; Jensen RH; Hassan TM; Mathiasen EG; Thomsen GM; Pedersen UG; Christensen M; Hilberg O; Arendrup MC
Antimicrob Agents Chemother; 2014 Sep; 58(9):5096-101. PubMed ID: 24936595
[TBL] [Abstract][Full Text] [Related]
9. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania.
Chowdhary A; Sharma C; van den Boom M; Yntema JB; Hagen F; Verweij PE; Meis JF
J Antimicrob Chemother; 2014 Nov; 69(11):2979-83. PubMed ID: 25006238
[TBL] [Abstract][Full Text] [Related]
10. First azole-resistant Aspergillus fumigatus isolates with the environmental TR
Ahangarkani F; Puts Y; Nabili M; Khodavaisy S; Moazeni M; Salehi Z; Laal Kargar M; Badali H; Meis JF
Mycoses; 2020 May; 63(5):430-436. PubMed ID: 32056319
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
[TBL] [Abstract][Full Text] [Related]
12. Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato.
Serrano-Lobo J; Gómez A; Reigadas E; Muñoz P; Escribano P; Guinea J;
Mycoses; 2023 Mar; 66(3):196-201. PubMed ID: 36305878
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
Astvad KMT; Hare RK; Arendrup MC
Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
[TBL] [Abstract][Full Text] [Related]
14. A Novel Environmental Azole Resistance Mutation in
Zhang J; Snelders E; Zwaan BJ; Schoustra SE; Meis JF; van Dijk K; Hagen F; van der Beek MT; Kampinga GA; Zoll J; Melchers WJG; Verweij PE; Debets AJM
mBio; 2017 Jun; 8(3):. PubMed ID: 28655821
[TBL] [Abstract][Full Text] [Related]
15. Trends in the activity of mold-active azole agents against
Pfaller MA; Carvalhaes CG; Rhomberg PR; Desphande LM; Castanheira M
J Clin Microbiol; 2024 Feb; 62(2):e0114123. PubMed ID: 38193696
[TBL] [Abstract][Full Text] [Related]
16. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain.
Escribano P; Rodríguez-Sánchez B; Díaz-García J; Martín-Gómez MT; Ibáñez-Martínez E; Rodríguez-Mayo M; Peláez T; García-Gómez de la Pedrosa E; Tejero-García R; Marimón JM; Reigadas E; Rezusta A; Labayru-Echeverría C; Pérez-Ayala A; Ayats J; Cobo F; Pazos C; López-Soria L; Alastruey-Izquierdo A; Muñoz P; Guinea J;
Clin Microbiol Infect; 2021 Aug; 27(8):1170.e1-1170.e7. PubMed ID: 33010446
[TBL] [Abstract][Full Text] [Related]
17. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
[TBL] [Abstract][Full Text] [Related]
19.
Raffetin A; Courbin V; Jullien V; Dannaoui E
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038263
[No Abstract] [Full Text] [Related]
20. Multicenter Study of Azole-Resistant Aspergillus fumigatus Clinical Isolates, Taiwan
Wu CJ; Liu WL; Lai CC; Chao CM; Ko WC; Wang HC; Dai CT; Hsieh MI; Choi PC; Yang JL; Chen YC
Emerg Infect Dis; 2020 Apr; 26(4):804-806. PubMed ID: 32186508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
